Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2026-03-03 @ 12:20 AM
Study NCT ID:
NCT02350218
Status:
UNKNOWN
Last Update Posted:
2018-07-06
First Post:
2015-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Efficacy of Eglandin® in Living Donor Liver Transplanted Patient (PROVISION)
Sponsor:
Asan Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-03
Start Date Type:
None
Primary Completion Date:
2018-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-12
Completion Date Type:
ESTIMATED
First Submit Date:
2015-01-20
First Submit QC Date:
None
Study First Post Date:
2015-01-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-05
Last Update Post Date:
2018-07-06
Last Update Post Date Type:
ACTUAL